معرفی
Marielle Pijnenburg is a researcher in the Department of Pediatrics at Erasmus MC, Faculty of Medicine. Her work is centered on pediatric respiratory health, with a focus on asthma, prematurity-related lung conditions, and long-term outcomes of neonatal respiratory disorders.
Her research interests include asthma, severe asthma, prematurity, lung development, and genotype-guided treatments. She actively investigates the respiratory consequences of moderate-to-late prematurity and explores modifiable risk factors. Her recent work also extends to post-COVID-19 conditions in children, analyzing epidemiological patterns based on acute disease severity.
The trends in her recent publications (2025) show a strong emphasis on clinical research, particularly randomized controlled trials (RCTs) and meta-analyses. Her work bridges translational pharmacogenomics (e.g., ADRB2 genotyping in asthma) with population-level outcomes, including cost-effectiveness and long-term sequelae. Key thematic areas include personalized medicine in pediatrics, respiratory outcomes of preterm birth, and post-viral syndromes.
She has contributed to significant collaborative research projects such as the PUFFIN and PACT trials, indicating active participation in funded, multi-center studies. While no formal advising list is provided, her involvement in doctoral theses and supervised work suggests mentorship roles within her research team.
Marielle Pijnenburg is part of a robust research network in pediatric pulmonology and allergy, collaborating with experts across Erasmus MC and external institutions. Her work is disseminated through high-impact journals such as Allergy, Pediatric Allergy and Immunology, and European Respiratory Review.
